| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.0086 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |